UNSPSC 41141940: Compound s (11-deoxycortisol) test system

In this classification, Compound s (11-deoxycortisol) test system connotes a device used to measure Compound s (11-deoxycortisol) levels. US FDA regulates Compound s (11-deoxycortisol) test system under 21 CFR 862.1185 and under FDA product code JKB.

UNSPSC 41141940 Compound s (11-deoxycortisol) test system is a Commodity code that in recent state and local practice covers diagnostic testing kits, reagent systems, and certified reference materials used in forensic drug analysis, toxicology screening, and laboratory validation operations. State and local governments procure these products primarily through forensic laboratories, public health departments, and criminal justice agencies for substance identification, method validation, and evidentiary sample analysis. The issuing bodies span state departments of public safety and health services, county forensic laboratories, and specialized crime lab divisions. Recent solicitations show Texas and Florida as active buyers, with Texas Department of Public Safety, Texas Health and Human Services Commission (procuring on behalf of the Department of State Health Services), and Pinellas County, Florida each posting multiple opportunities in the past four months.

Recent representative opportunities include the Texas Department of Public Safety's IFB 405-26R0008445A (posted July 9, 2026; due July 23, 2026) soliciting Direct ELISA testing kits for cannabinoids, opiates, PCP, amphetamines, and other controlled substances plus phosphate-buffered saline solution, with 12 line items ranging from 3 to 30 units each and delivery to the Crime Lab Division in Austin; Pinellas County, Florida's ITQ #26-0305-ITQ (posted and due April 23, 2026) procuring 131 line items of certified drug reference standards with ISO/IEC 17025:2017 accreditation for toxicology and seized drug analysis, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with approximately $49,034.00 designated for supplies, and offering five percent price preference to Florida Certified Small Business Enterprises; and the Texas Health and Human Services Commission's IFB HHS0016902v2 (due January 29, 2026) for QIAxcel and QIAamp DNA screening kits serving the state laboratory, with historical annual procurement value between $25,050.00 and $30,000.00 in Fiscal Year 2025. HUB subcontracting plans are required or encouraged on Texas procurements; Pinellas County extends set-aside preference to certified SBEs.